First symptoms of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) include limb weakness and loss of muscle control, worsening as death of brain and nervous system cells progresses. Itâs the most common form of motor neuron disease, with an estimatedâŻ1,700 peopleâŻin the UK being diagnosed annually, and has a life expectancy of two to five years. Here, innovative imaging andâŻbehaviourâŻquantification techniques are being used to study the molecular mechanisms of ALS in a worm model bearing a gene mutation like that underlying a form of the human disease. Compared to control worms (top) proteins implicated in ALS accumulate in the worm model (red, lower panel). ObservingâŻneurodegenerationâŻand locomotor defects in these worms allows comparison with ALS observations in humans. Translating this research into the clinic could provide novel treatments for ALS patients and generating other such worm models could also help unpick the complex molecular basis for a myriad of rare genetic diseases.âŻ
Research in collaboration with the MRC London Institute of Medical Sciences' Behavioural Phenomics group
Written by Daniella Gimbosh
Image from work by Yoshifumi Sonobe and colleagues
The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA
Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)
Published in Nature Communications, November 2021
You can also follow BPoD on Instagram, Twitter and Facebook